Literature DB >> 30470863

Technical feasibility of semiautomatic three-dimensional threshold-based cardiac computed tomography quantification of left ventricular mass.

Hyun Woo Goo1.   

Abstract

BACKGROUND: Semiautomatic three-dimensional (3-D) threshold-based cardiac computed tomography (CT) quantification has not been attempted for left ventricular mass.
OBJECTIVE: To evaluate the technical feasibility of semiautomatic 3-D threshold-based cardiac CT quantification of left ventricular mass in patients with various degrees of left ventricular hypertrophy.
MATERIALS AND METHODS: In 99 patients, cardiac CT was utilized to quantify ventricular volume and mass by using a semiautomatic 3-D threshold-based method. Left ventricular mass values were compared between the end-systole and the end-diastole. Volumetric parameters were compared among three left ventricular hypertrophy groups (definite, borderline, none). The reproducibility was assessed. The t-test, one-way analysis of variance and Pearson correlation were used.
RESULTS: There were no technical failures. The left ventricular mass between the two sessions exhibited a small mean difference of 2.3±1.1% (mean±standard deviation). The indexed mass values were significantly higher at the end-systole than at the end-diastole (71.4±42.9 g/m2 vs. 65.9±43.3 g/m2, P<0.001), with significant correlation (R=0.99, P<0.001). The definite group (83.5±41.3 g/m2) showed statistically significantly higher indexed mass values than the borderline and none groups (64.7±26.9 and 55.6±23.9 g/m2, respectively; P<0.03), while demonstrating no statistically significant difference between the latter two groups (P>0.05). Left ventricular volume-mass and mass-volume ratios could be calculated in all three groups.
CONCLUSION: CT quantification of left ventricular mass using semiautomatic 3-D threshold-based segmentation is feasible with high reproducibility and the mass values and its ratios with ventricular volumes may be used in patients with various degrees of left ventricular hypertrophy.

Entities:  

Keywords:  Children; Computed tomography; Heart; Image post processing; Left ventricular hypertrophy; Left ventricular mass; Repeatability; Threshold-based segmentation; Young adults

Mesh:

Year:  2018        PMID: 30470863     DOI: 10.1007/s00247-018-4303-9

Source DB:  PubMed          Journal:  Pediatr Radiol        ISSN: 0301-0449


  37 in total

1.  Semiautomatic three-dimensional CT ventricular volumetry in patients with congenital heart disease: agreement between two methods with different user interaction.

Authors:  Hyun Woo Goo; Sang-Hyub Park
Journal:  Int J Cardiovasc Imaging       Date:  2015-08-29       Impact factor: 2.357

2.  Reproducibility of left and right ventricular mass measurements with cardiac CT.

Authors:  Florian Schwarz; Richard Takx; U Joseph Schoepf; Yeong Shyan Lee; Balazs Ruzsics; Eva Maria Gassner; Salvatore Chiaramida; Thomas Henzler
Journal:  J Cardiovasc Comput Tomogr       Date:  2011-08-07

3.  Correlation of trabeculae and papillary muscles with clinical and cardiac characteristics and impact on CMR measures of LV anatomy and function.

Authors:  Michael L Chuang; Philimon Gona; Gilion L T F Hautvast; Carol J Salton; Susan J Blease; Susan B Yeon; Marcel Breeuwer; Christopher J O'Donnell; Warren J Manning
Journal:  JACC Cardiovasc Imaging       Date:  2012-11

4.  Improved left ventricular mass quantification with partial voxel interpolation: in vivo and necropsy validation of a novel cardiac MRI segmentation algorithm.

Authors:  Noel C F Codella; Hae Yeoun Lee; David S Fieno; Debbie W Chen; Sandra Hurtado-Rua; Minisha Kochar; John Paul Finn; Robert Judd; Parag Goyal; Jesse Schenendorf; Matthew D Cham; Richard B Devereux; Martin Prince; Yi Wang; Jonathan W Weinsaft
Journal:  Circ Cardiovasc Imaging       Date:  2011-11-21       Impact factor: 7.792

5.  Impact of left ventricular volume/mass ratio on diastolic function.

Authors:  Adisai Buakhamsri; Zoran B Popovic; Jingna Lin; Pascal Lim; Neil L Greenberg; Allen G Borowski; W H Wilson Tang; Allan L Klein; Harry M Lever; Milind Y Desai; James D Thomas
Journal:  Eur Heart J       Date:  2009-03-20       Impact factor: 29.983

Review 6.  CT radiation dose optimization and estimation: an update for radiologists.

Authors:  Hyun Woo Goo
Journal:  Korean J Radiol       Date:  2011-12-23       Impact factor: 3.500

7.  Effect of papillary muscles and trabeculae on left ventricular measurement using cardiovascular magnetic resonance imaging in patients with hypertrophic cardiomyopathy.

Authors:  Eun-Ah Park; Whal Lee; Hyung-Kwan Kim; Jin Wook Chung
Journal:  Korean J Radiol       Date:  2015-01-09       Impact factor: 3.500

8.  Ex vivo cardiovascular magnetic resonance measurements of right and left ventricular mass compared with direct mass measurement in excised hearts after transplantation: a first human SSFP comparison.

Authors:  Nicholas J Farber; Sahadev T Reddy; Mark Doyle; Geetha Rayarao; Diane V Thompson; Peter Olson; Jerry Glass; Ronald B Williams; June A Yamrozik; Srinivas Murali; Robert Ww Biederman
Journal:  J Cardiovasc Magn Reson       Date:  2014-10-01       Impact factor: 5.364

9.  Assessment of Left Ventricular Mass and Hypertrophy by Cardiovascular Magnetic Resonance Imaging in Pediatric Hypertension.

Authors:  Katarina Supe-Markovina; James C Nielsen; Muzammil Musani; Laurie E Panesar; Robert P Woroniecki
Journal:  J Clin Hypertens (Greenwich)       Date:  2016-03-14       Impact factor: 3.738

10.  Quantitative Assessment of Left Ventricular Function and Myocardial Mass: A Comparison of Coronary CT Angiography with Cardiac MRI and Echocardiography.

Authors:  Bedia Kara; Alaaddin Nayman; Ibrahim Guler; Enes Elvin Gul; Mustafa Koplay; Yahya Paksoy
Journal:  Pol J Radiol       Date:  2016-03-09
View more
  1 in total

1.  Pattern Analysis of Left Ventricular Remodeling Using Cardiac Computed Tomography in Children with Congenital Heart Disease: Preliminary Results.

Authors:  Hyun Woo Goo; Sang Hyub Park
Journal:  Korean J Radiol       Date:  2020-06       Impact factor: 3.500

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.